Medical Diagnostic Kit Supply and Manufacturing

The contract entails the manufacture and supply of synthetic nucleic acid-based respiratory panel controls, each containing six quality control runs, designed to ensure accurate and reliable diagnostic testing. All products must strictly adhere to FDA regulations, ISO 13485 quality management standards, and Defense Logistics Agency specifications to meet the rigorous requirements of medical and military healthcare applications. The work is to be performed under a subcontract arrangement for the Department of Defense, with performance directed to the APO 09227-0000 location, reflecting its alignment with federal medical supply chain operations. The solicitation was posted on August 5, 2026, with responses due by August 11, 2026, and the North American Industry Classification System code 325414 confirms the focus on pharmaceutical and medicinal chemical manufacturing. Compliance with these standards ensures the controls are suitable for use in clinical diagnostics across defense and civilian medical systems.